These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11603115)

  • 21. Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.
    Saltz LB; Douillard JY; Pirotta N; Alakl M; Gruia G; Awad L; Elfring GL; Locker PK; Miller LL
    Oncologist; 2001; 6(1):81-91. PubMed ID: 11161231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer: chemotherapy treatment overview.
    Royce ME; Medgyesy D; Zukowski TH; Dwivedy S; Hoff PM; Pazdur R
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):40-6. PubMed ID: 11200148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.
    Benson AB
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):28-34. PubMed ID: 9830622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of capecitabine in the treatment of colorectal cancer.
    Rothenberg ML
    Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC).
    Wein A; Siebler J; Wolff K; Ostermeier N; Busse D; Hagel A; Koch F; Merx K; Neurath MF; Hofheinz RD
    Anticancer Res; 2017 Jul; 37(7):3771-3779. PubMed ID: 28668873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New developments in systemic chemotherapy in advanced colorectal cancer.
    Cats A
    Scand J Gastroenterol Suppl; 2003; (239):78-86. PubMed ID: 14743888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic treatment of advanced colorectal carcinoma.
    van Laarhoven HW; Punt CJ
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):283-9. PubMed ID: 15195891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada.
    Maroun J; Asche C; Romeyer F; Mukherjee J; Cripps C; Oza A; Skillings J; Letarte J
    Pharmacoeconomics; 2003; 21(14):1039-51. PubMed ID: 13129416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer.
    Thirion P; Wolmark N; Haddad E; Buyse M; Piedbois P
    Ann Oncol; 1999 Nov; 10(11):1317-20. PubMed ID: 10631459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New therapeutic options in chemotherapy of advanced colorectal cancer].
    Reimer P; Rückle-Lanz H
    Med Klin (Munich); 2001 Oct; 96(10):593-8. PubMed ID: 11715331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent progress of chemotherapy for colorectal cancer].
    Ishiguro A; Shitara K; Munakata M; Saitoh S; Sakata Y
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2017-23. PubMed ID: 16352922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New chemotherapeutic strategies in colorectal cancer.
    Moehler M; Teufel A; Galle PR
    Recent Results Cancer Res; 2005; 165():250-9. PubMed ID: 15865041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weekly oxaliplatin, high-dose infusional 5-fluorouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinoma.
    Kallen KJ; Hofmann MA; Timm A; Gödderz W; Galle PR; Heike M
    Z Gastroenterol; 2000 Feb; 38(2):153-7. PubMed ID: 10721170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil.
    Hartmann JT; Oechsle K; Jäger E; Reis HE; Haag C; Niederle N; Wilke HJ; Pflüger KH; Batran SA; Büchele T; Hofheinz RD; Kanz L; Bokemeyer C
    Anticancer Drugs; 2004 Jun; 15(5):473-7. PubMed ID: 15166621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Where do we stand with 5-fluorouracil?
    Schmoll HJ; Büchele T; Grothey A; Dempke W
    Semin Oncol; 1999 Dec; 26(6):589-605. PubMed ID: 10606252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
    Cunningham D; Coleman R
    Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is repeated treatment with a 5-fluorouracil-based regimen useful in colorectal cancer?
    Goldberg RM
    Semin Oncol; 1998 Oct; 25(5 Suppl 11):21-8. PubMed ID: 9786313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing the use of irinotecan in colorectal cancer.
    Cunningham D; Maroun J; Vanhoefer U; Van Cutsem E
    Oncologist; 2001; 6 Suppl 4():17-23. PubMed ID: 11585970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer.
    Chayahara N; Tamura T; Yamamori M; Kadowaki Y; Okuno T; Miki I; Tsuda M; Nishisaki H; Maeda T; Inoue Y; Okumura K; Azuma T; Kasuga M; Sakaeda T; Hirai M
    Am J Clin Oncol; 2009 Feb; 32(1):56-60. PubMed ID: 19194126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.